Literature DB >> 3088640

Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity.

E T Iwamoto.   

Abstract

The effects of phencyclidine (PCP) on locomotor activity were compared to those of the stereoisomers of N-allylnormetazocine (NAN) after acute administration to rats. PCP produced swaying and falling movements, increased sniffing behavior, and enhanced horizontal locomotor activity. d-NAN also induced swaying, falling, sniffing behavior and locomotion, and decreased rearing behavior. l-NAN decreased rearing activity, depressed locomotion, antagonized morphine antinociception and precipitated the morphine-withdrawal syndrome. Sensitization to drug-induced sniffing, rearing and locomotion developed after four daily injections of PCP, d-NAN or l-NAN in rats. Rats which were sensitized to PCP-induced locomotion, sniffing, and rearing were also cross-sensitized to both d-NAN and l-NAN. Animals sensitized to the effects of either d- or l-NAN exhibited cross-sensitization to PCP. There was little evidence that the cross-sensitization between the three agents was stereoselective. These data indicate that the acute effects of PCP are similar to those of d-NAN, but differ from l-NAN, the only agent of the three with opioid antagonist properties. The data further indicate that as sensitization to the motor effects develops during repeated administration of PCP, d-NAN or l-NAN, the differences among the three agents become less apparent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088640     DOI: 10.1007/bf00310633

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Quantitative aspects of precipitated abstinence in morphine-dependent rats.

Authors:  E Wei; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1973-02       Impact factor: 4.030

2.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

3.  Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists.

Authors:  E T Iwamoto
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

Review 4.  Multiple opioid receptors.

Authors:  E T Iwamoto; W R Martin
Journal:  Med Res Rev       Date:  1981       Impact factor: 12.944

5.  Phencyclidine-induced stereotyped behavior in monkeys: antagonism by pimozide.

Authors:  R F Schlemmer; J A Jackson; K L Preston; J P Bederka; D L Garver; J M Davis
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

6.  Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectra in the rat. Stereospecificity and naloxone antagonism.

Authors:  G A Young; N Khazan
Journal:  Neuropharmacology       Date:  1984-10       Impact factor: 5.250

7.  Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membranes.

Authors:  J P Vincent; B Kartalovski; P Geneste; J M Kamenka; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats.

Authors:  K T Brady; R L Balster; E L May
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

9.  Antinociceptive studies of the optical isomers of N-allylnormetazocine (SKF 10,047).

Authors:  M D Aceto; E L May
Journal:  Eur J Pharmacol       Date:  1983-07-22       Impact factor: 4.432

10.  Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys.

Authors:  J L Katz; R D Spealman; R D Clark
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

View more
  5 in total

1.  Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration.

Authors:  Angelica Rocha; Nigel Hart; Keith A Trujillo
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

2.  Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.

Authors:  Adam L Halberstadt; James Hyun; Michael A Ruderman; Susan B Powell
Journal:  Pharmacol Biochem Behav       Date:  2016-05-26       Impact factor: 3.533

3.  Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine.

Authors:  Hyun-Sang Cho; Deepak C D'Souza; Ralitza Gueorguieva; Edward B Perry; Steven Madonick; Laurence P Karper; Anissa Abi-Dargham; Aysenil Belger; Walid Abi-Saab; Deborah Lipschitz; Alexandre Bennet; John P Seibyl; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

4.  Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.

Authors:  R Dall'Olio; O Gandolfi; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Nasal respiration is necessary for ketamine-dependent high frequency network oscillations and behavioral hyperactivity in rats.

Authors:  Jacek Wróbel; Władysław Średniawa; Gabriela Jurkiewicz; Jarosław Żygierewicz; Daniel K Wójcik; Miles Adrian Whittington; Mark Jeremy Hunt
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.